IBT
PRTK

International Biotechnology Trust’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

International Biotechnology Trust’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-103,500
Closed -$766K – 54
2018
Q3 		$766K Hold
103,500
– – 0.36% 45
2018
Q2 		$1.05M Hold
103,500
– – 0.4% 44
2018
Q1 		$1.35M Sell
103,500
-150,000
-59% -$2.23M 0.53% 43
2017
Q4 		$4.54M Buy
253,500
+51,500
+25% +$1.07M 1.6% 23
2017
Q3 		$5.07M Buy
202,000
+144,000
+248% +$3.35M 1.97% 16
2017
Q2 		$1.4M Buy
+58,000
New +$1.28M 0.53% 43

Other funds holding PRTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $190M AUM 50.42% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

International Biotechnology Trust's PRTK Position: Q4 2018 in Review

International Biotechnology Trust sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2018, closing a stake of 103,500 shares — an estimated $766K sold.

International Biotechnology Trust first reported a position in PRTK in Q2 2017 and held it in 6 quarters. The position peaked at $5.07M in Q3 2017. 102 funds tracked by Wall St. Rank hold PRTK as of Q4 2018.

  • International Biotechnology Trust reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 103,500 Paratek Pharmaceuticals, Inc. shares in Q4 2018, an estimated $766K.
  • International Biotechnology Trust first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2017 and held it in 6 quarters.
  • International Biotechnology Trust's Paratek Pharmaceuticals, Inc. position peaked at $5.07M in Q3 2017.
  • 102 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2018.

Based on International Biotechnology Trust's 13F filing for Q4 2018, filed 14 Feb 2019.